SG Americas Securities’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75K | Buy |
21,979
+6,402
| +41% | +$21.8K | ﹤0.01% | 2375 |
|
|
2025
Q1 | $35K | Buy |
+15,577
| New | +$35K | ﹤0.01% | 2910 |
|
|
2023
Q2 | – | Sell |
-36,208
| Closed | -$273K | – | 1896 |
|
|
2023
Q1 | $273K | Buy |
+36,208
| New | +$273K | ﹤0.01% | 1999 |
|
|
2022
Q4 | – | Sell |
-160,643
| Closed | -$1.59M | – | 2684 |
|
|
2022
Q3 | $1.59M | Buy |
160,643
+150,966
| +1,560% | +$1.49M | 0.02% | 589 |
|
|
2022
Q2 | $103K | Buy |
+9,677
| New | +$103K | ﹤0.01% | 2832 |
|